U.S. Markets open in 2 hrs, 22 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,058.64 | 150.25 | 1.52% |
| NASDAQ | 2,150.87 | 24.82 | 1.17% |
| S&P 500 | 1,070.52 | 13.78 | 1.30% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 60.95 11:08 AM EST | |
|---|---|---|
| Day High | 62.16 09:30 AM EST |
|
| Range | 1.21 |
| Volume | 179,773 | |
|---|---|---|
| 30-Day Avg Vol | 113,000 |
|
| Difference | 59.09% |
| Market Cap | 2.27 B | |
|---|---|---|
| Mkt Cap Chg | 372,466 |
| Shares Out | 37.24 M | |
|---|---|---|
| % Shrs Traded | 0.48% | |
| 1yr EPS Est | 3.038 |
| 52-Wk Low | 45.38 | |
|---|---|---|
| 52-Wk High | 69.95 |
|
| Range | 24.57 |
| Prev Close | 61.19 2/8/10 | |
|---|---|---|
| Today's Open | 61.75 | |
| Change | 0.92% |
| Dividend (TTM) | 1.02 | |
|---|---|---|
| Div Yield (TTM) | 1.69% | |
| Ex-Div Date | 02/10/2010 | |
| Div Date | 02/26/2010 |
|
| Short Interest | 653,378.00 |
| Revenue (LFY) | 263.95 M | |
|---|---|---|
| Earnings (LFY) | 105.24 M | |
| Earnings (MRQ) | 24.72 M | |
| Next Earn Est | 0.795 | |
| Next Earnings | 04/26/2010 |
|
| EPS (TTM) | 2.80 | |
| 1yr EPS Growth | 8.50% |
| P/E Ratio (TTM) | 21.86 | |
|---|---|---|
| P/E Ratio (Fwd) | 20.00 | |
| PEG Ratio | 1.95 | |
| Return on Equity | 24.44 | |
| Beta | 0.68 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
TECHNE has biotechnology research down to an art form. The firm's main subsidiary, Research and Diagnostic Systems (R&D Systems), makes cytokines, which are purified proteins that affect cell behavior, ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.795 4/26/10 | — — |
—
—
|
| Last Quarter | 0.683 12/31/09 | 0.66 12/31/09 |
-0.023
Missed
|
| 2 Quarters Ago | 0.70 9/30/09 | 0.72 9/30/09 |
0.02
Beat
|
| Quarterly - 12/31/2009 | Annual - 2009 | |
|---|---|---|
| Total Revenue | 65.52 M | 263.96 M |
| Gross Profit | 51.95 M | 207.51 M |
| Operating Income | 36.55 M | 150.78 M |
| Net Income | 24.72 M | 105.24 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts